To evaluate the efficacy of iPSC CD276-targeted CAR-NK cells against ESCC cells, we generated a CD276-expressing ESCC cell line (Kyse-150) xenograft BNDG mouse model. The gene discussed is CD276; the disease is esophageal squamous cell carcinoma.